{"title":"Treatment of Essential Tremor with Multi-Modal Nutritional Therapy in a Teenage Patient","authors":"M. R. Novak","doi":"10.15406/jnsk.2017.07.00242","DOIUrl":null,"url":null,"abstract":"Essential tremor (ET) the most common movement disorder, affecting 1% of the population across all ages and a significantly higher proportion of older adults [1]. However, ET also affects children, and, although often described as “benign”, the condition interferes with activities of daily living in over 90% of individuals [2]. Pharmacological therapy remains first-line ET treatment, with propranolol (a beta-blocker) and primidone (a barbiturate anti-convulsant) first-choice agents [3]. However, over 50% of patients do not respond to therapy and many experience sideeffects including sleepiness and cognitive defects, prompting nonadherence to medication in many cases [4].","PeriodicalId":106839,"journal":{"name":"Journal of Neurology and Stroke","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology and Stroke","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jnsk.2017.07.00242","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Essential tremor (ET) the most common movement disorder, affecting 1% of the population across all ages and a significantly higher proportion of older adults [1]. However, ET also affects children, and, although often described as “benign”, the condition interferes with activities of daily living in over 90% of individuals [2]. Pharmacological therapy remains first-line ET treatment, with propranolol (a beta-blocker) and primidone (a barbiturate anti-convulsant) first-choice agents [3]. However, over 50% of patients do not respond to therapy and many experience sideeffects including sleepiness and cognitive defects, prompting nonadherence to medication in many cases [4].